Finance
Results: 433-444 of 44685

FlexTrade Expands Portfolio Risk and Analytics Capabilities Through Strategic Partnership with Portx

ONE CARMEL LAUNCHES RESIDENTIAL SALES, INTRODUCING A NEW STANDARD FOR COASTAL LIVING IN CARMEL VALLEY

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)








